IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...
IRVINE, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from ...
IRVINE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- In recognition of World Thrombosis Day, Inari Medical, Inc. (NARI) (“Inari”) a medical device company with a mission to treat and transform the lives ...
Inari’s Defiance clinical trial is treating patients with deep vein thrombosis using its ClotTriever system Inari Medical Inc., which designs medical devices to remove large blood clots from veins, is ...
Inari Medical, Inc. (NASDAQ:NARI) is a medical device company that develops, manufactures, and markets devices for the interventional treatment of venous diseases. Its products primarily comprise ...
On Monday, Stryker Corporation (NYSE:SYK) agreed to acquire Inari Medical Inc. (NASDAQ:NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Inari Medical Inc., which began in 2011, tried to prove for years it’s pioneering a new way of treating patients with blood clots in their veins. Doctors nowadays are clearly impressed, having treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback